KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $199,000 | +74.6% | 1,104 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $114,000 | +31.0% | 1,104 | -0.5% | 0.00% | 0.0% |
| Q1 2017 | $87,000 | +8600.0% | 1,110 | +6066.7% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 18 | +157.1% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 7 | +40.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 5 | -50.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 10 | +150.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $135,991,000 | 55.96% |
| Lamond Capital Partners LLC | 365,900 | $21,101,000 | 13.82% |
| EcoR1 Capital, LLC | 438,400 | $25,283,000 | 12.80% |
| DSAM Partners (London) Ltd | 399,571 | $23,043,000 | 6.08% |
| Silver Rock Financial LLC | 476,563 | $27,483,000 | 5.08% |
| Cormorant Asset Management, LP | 255,000 | $14,706,000 | 2.27% |
| Opaleye Management Inc. | 76,000 | $4,383,000 | 2.22% |
| Ghost Tree Capital, LLC | 60,000 | $3,460,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 110,970 | $6,400,000 | 1.09% |
| PURA VIDA INVESTMENTS, LLC | 44,250 | $2,552,000 | 0.94% |